• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ortin Global Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 17472.0
  • ISIN : INE749B01020
15.60 1 (4.98%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    15.60
  • Today’s High

    15.60
  • Open

    15.60
  • Perv Close

    14.86
  • 52W Low

    9.64
  • 52W High

    24.82

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    12.68

  • Div & Yield %

    0.00

  • Book Value(₹)

    2.44

  • Debt-Equity Ratio

    4.98

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    12.68

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.13

  • BV (₹)

    2.40

  • Sales( ₹ in Cr.)

    0.34

  • NP (in Cr.)

    -0.87

  • NP Var(%)

    86.0

  • Div%

    0.0

  • CPS (₹)

    -1.00

  • EPS (₹)

    -1.10

  • Traded Value (₹ in Lakhs)

    13.12

  • 52 Week High

    24.82

  • 52 Week Low

    9.64

  • Price BSE

    16.0

  • Price NSE

    16.00

  • Market Capital( in Cr.)

    13.12

  • P/C Ratio

    -15.20

  • P/E Ratio

    -15.00

  • Price Vs.BV

    -1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2.11 6.02 8.23 8.17 197.39 167.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2.11 6.02 8.23 8.17 197.39 167.76
Other Income 0.17 0.04 0.19 0.05 0.19 0.13
Stock Adjustments -1.33 0.50 -0.05 0.13 10.53 6.73
Total Income 0.95 6.56 8.37 8.35 208.11 174.62
EXPENDITURE :            
Raw Materials 2.38 3.89 4.61 4.08 165.15 141.54
Power and Fuel Cost 0.17 0.24 0.22 0.11 5.39 5.67
Employee Cost 0.48 0.68 0.74 0.85 4.72 3.68
Other Manufacturing Expenses 0.50 0.29 0.42 0.55 20.66 12.16
Selling and Administration Expenses 1.31 0.72 1.42 1.06 4.71 3.42
Miscellaneous Expenses 2.48 0.20 0.41 0.40 1.60 1.34
Employee Benefit Expenses 0.48 0.68 0.74 0.85 4.72 3.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7.31 6.03 7.81 7.05 202.23 167.81
Operating Profit -6.37 0.54 0.57 1.29 5.88 6.81
Interest 0.48 0.40 0.81 0.87 3.21 3.22
Gross Profit -6.85 0.14 -0.24 0.42 2.67 3.59
Depreciation 0.23 0.25 0.29 0.29 1.96 1.75
Profit Before Tax -7.08 -0.11 -0.53 0.13 0.71 1.84
Current Tax 1.29 0.00 0.00 0.06 1.06 0.54
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.33 -0.02 -0.13 -0.87 0.23 0.02
Reported Net Profit -8.04 -0.09 -0.40 0.95 -0.56 1.28
Extraordinary Items -1.76 -0.02 0.00 0.00 -0.01 0.00
Adjusted Net Profit -6.28 -0.07 -0.40 0.95 -0.55 1.28
Adjustment below Net Profit 0.00 0.00 0.00 -4.38 -0.71 -0.26
P & L Balance brought forward 2.09 2.18 2.58 6.02 7.30 6.28
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.95 2.09 2.18 2.58 6.02 7.30
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.89 -0.12 -0.49 1.16 -0.33 0.76
Earnings Per Share(Adj)-Unit Curr -9.89 -0.12 -0.49 1.16 -0.33 0.76
Book Value 3.47 13.36 13.47 13.97 14.06 14.81
Book Value(Adj)-Unit Curr 3.47 13.36 13.47 13.97 14.06 14.81

Shareholding Pattern

  • Promoter Group

    1.23%

  • Public Share Holding

    98.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,300 1.23 100,300 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,300 1.23 100,300 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 530,728 6.53 530,728 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 530,728 6.53 530,728 2
2] Non Institution
Bodies Corporate 249,022 3.06 248,158 39
Clearing Members 432 0.01 432 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 100,179 1.23 100,179 55
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 185,721 2.28 185,241 185
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,948,203 23.96 1,948,203 29
Individuals holding nominal share capital up to Rs. 1 lakh 5,016,807 61.70 4,934,751 11,719
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,500,364 92.24 7,416,964 12,028
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,131,392 100.00 8,047,992 12,034

Company Background

Ortin Global LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ortin Global Ltd
  • BSE Code : 17472.0
  • ISIN : INE749B01020
  • Incorporation Year

    1986

  • Registered Office

    D No 1-8-B4 Ground Floor F3
    HIG Block-4 Street No 3, Hyderabad,
    Telangana-500044

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    S Murali Krishna Murthy

  • Company Secretary

  • Auditor

    Mathesh & Ramana

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Ortin Global Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ortin Global 16.14 2.28 2.11 -15.52 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10